Purpose: A modified Clavien classification system has been proposed to grade perioperative complications. We share our experience in grading the complications of percutaneous nephrolithotomy (PNL), according to this new classification. Methods: A total of 809 PNLs performed between 2010 and 2014 were reviewed retrospectively. The modified Clavien classification system, which classifies the perioperative complications into 5 grades, was applied. Grade wise comparison of complications between the patients with simple and complex calculi was done. We also carried out a univariate analysis of different predictors of complications after surgery. Results: A total of 253 perioperative complications were observed in 237 (29.29%) patients. Most complications were related to bleeding and urinary leakage. Patients with complex calculi had significantly more number of complications across all Clavien groups. In a univariate analysis, positive preoperative urine culture and multiple access for stone clearance were identified to be the independent predictors of complications. Conclusion: The modified Clavien system is a simplistic grading system for classification of postoperative complications. However, it suffers from various shortcomings. Therefore, till the proposition of a more comprehensive classification system, the modified Clavien system is useful for reporting the complications and short-term outcomes of PNL.

Keywords:
Percutaneous nephrolithotomy, Complications, Calculus, Clavien
1.
Fernström I, Johansson B: Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol 1976;10:257-259.
2.
Preminger GM, Assimos DG, Lingeman JE, Nakada SY, Pearle MS, Wolf JS Jr: AUA guideline on management of staghorn calculi: diagnosis and treatment recommendations. J Urol 2005;173:1991-2000.
3.
Matlaga BR, Kim SC, Lingeman JE: Improving outcomes of percutaneous nephrolithotomy. EAU Update Series 2005;3:37-43.
4.
Michel MS, Trojan L, Rassweiler JJ: Complications in percutaneous nephrolithotomy. Eur Urol 2007;51:899-906.
5.
Arslan MS, Zeytun H, Basuguy E, Arslan S, Aydogdu B, Okur MH: The outcome of percutaneous nephrolithotomy using intravenous catheter for obtaining percutaneous access as a treatment for renal stone disease in children: a pilot study. Urol J 2016;13:2502-2508.
6.
Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205-213.
7.
Gonzalgo ML, Pavlovich CP, Trock BJ, Link RE, Sullivan W, Su LM: Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy. J Urol 2005;174:135-139.
8.
Kocak B, Koffron AJ, Baker TB, Salvalaggio PR, Kaufman DB, Fryer JP, Abecassis MM, Stuart FP, Leventhal JR: Proposed classification of complications after live donor nephrectomy. Urology 2006;67:927-931.
9.
De la Rosette JJ, Zuazu JR, Tsakiris P, Elsakka AM, Zudaire JJ, Laguna MP, de Reijke TM: Prognostic factors and percutaneous nephrolithotomy morbidity: a multivariate analysis of a contemporary series using the Clavien classification. J Urol 2008;180:2489-2493.
10.
Tefekli A, Ali Karadag M, Tepeler K, Sari E, Berberoglu Y, Baykal M, Sarilar O, Muslumanoglu AY: Classification of percutaneous nephrolithotomy complications using the modified Clavien grading system: looking for a standard. Eur Urol 2008;53:184-190.
11.
Rassweiler JJ, Renner C, Eisenberger F: The management of complex renal stones. BJU Int 2000;86:919-928.
12.
Muslumanoglu AY, Tefekli A, Karadag MA, Tok A, Sari E, Berberoglu Y: Impact of percutaneous access point number and location on complication and success rates in percutaneous nephrolithotomy. Urol Int 2006;77:340- 346.
13.
Lee WJ, Smith AD, Cubelli V, Badlani GH, Lewin B, Vernace F, Cantos E: Complications in percutaneus nephrolitotomy. AJR Am J Roentgenol 1987;148:177-180.
14.
Mousavi-Bahar SH, Mehrabi S, Moslemi MK: Percutaneous nephrolithotomy complications in 671 consecutive patients: a single-center experience. Urol J 2011;8:271-276.
15.
Labate G, Modi P, Timoney A, Cormio L, Zhang X, Louie M, Grabe M, de la Rosette J: The percutaneous nephrolithotomy global study: classification of complications. J Endourol 2011;25:1275-1280.
16.
Gutierrez J, Smith A, Geavlete P, Shah H, Kural AR, de Sio M, Amón Sesmero JH, Hoznek A, de la Rosette J: Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol 2013; 31:1135-1140.
17.
El-Assmy AM, Shokeir AA, Mohsen T, El-Tabey N, El-Nahas AR, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany HA: Renal access by urologist or radiologist for percutaneous nephrolithotomy — is it still an issue? J Urol 2007;178:916-920.
18.
El-Nahas AR, Shokeir AA, El-Assmy AM, Mohsen T, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany HA: Post-percutaneous nephrolithotomy extensive hemorrhage: a study of risk factors. J Urol 2007;177:576-579.
19.
Srivastava A, Singh KJ, Suri A, Dubey D, Kumar A, Kapoor R, Mandhani A, Jain S: Vascular complications after percutaneous nephrolithotomy: are there any predictive factors? Urology 2005;66:38-40.
20.
Moreno-Palacios J, Maldonado-Alcaraz E, Montoya-Martínez G, Rivas-Ruiz R, Cedillo-López U, Okhunov Z, Serrano-Brambila EA: Prognostic factors of morbidity in patients undergoing percutaneous nephrolithotomy. J Endourol 2014;28:1078-1084.
21.
Munver R, Delvecchio FC, Newman GE, Preminger GM: Critical analysis of supracostal access for percutaneous renal surgery. J Urol 2001;166:1242-1246.
22.
Canes D, Hegarty NJ, Kamoi K, Haber GP, Berger A, Aron M, Desai MM: Functional outcomes following percutaneous surgery in the solitary kidney. J Urol 2009;181:154- 160.
23.
Bilen C Y, Inci K, Kocak B, Tan B, Sarikaya S, Sahin A: Impact of percutaneous nephrolithotomy on estimated glomerular filtration rate in patients with chronic kidney disease. J Endourol 2008;22:895-900.
24.
El-Assmy AM, Shokeir AA, El-Nahas AR, Shoma AM, Eraky I, El-Kenawy MR, El-Kappany HA: Outcome of percutaneous nephrolithotomy: effect of body mass index. Eur Urol 2007;52:199-204.
25.
Torrecilla Ortiz C, Meza Martinez AI, Vicens Morton AJ, Vila Reyes H, Colom Feixas S, Suarez Novo JF, Franco Miranda E: Obesity in percutaneous nephrolithotomy. Is body mass index really important? Urology 2014; 84:538-543.
26.
Tefekli A, Kurtoglu H, Tepeler K, Karadag MA, Kandirali E, Sari E, Baykal M, Muslumanoglu AY: Does the metabolic syndrome or its components affect the outcome of percutaneous nephrolithotomy? J Endourol 2008;22:35-40.
27.
Hruza M, Weiss HO, Pini G, Goezen AS, Schulze M, Teber D, Rassweiler JJ: Complications in 2200 consecutive laparoscopic prostatectomies: standardized evaluation and analysis of learning curves. Eur Urol 2010; 58:733-741.
28.
de la Rosette JJ, Opondo D, Daels FP, Giusti G, Serrano Á, Kandasami SV, Wolf JS Jr, Grabe M, Gravas S: Categorisation of complications and validation of the Clavien score for percutaneous nephrolithotomy. Eur Urol 2012;62:246-255.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.